nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—CYP3A4—bone cancer	0.211	1	CbGaD
Verapamil—ABCC10—Doxorubicin—bone cancer	0.0582	0.0894	CbGbCtD
Verapamil—ABCC10—Methotrexate—bone cancer	0.0564	0.0866	CbGbCtD
Verapamil—ABCC3—Cisplatin—bone cancer	0.0546	0.0839	CbGbCtD
Verapamil—ABCC1—Epirubicin—bone cancer	0.0423	0.0649	CbGbCtD
Verapamil—ABCC3—Doxorubicin—bone cancer	0.0366	0.0562	CbGbCtD
Verapamil—ABCC3—Methotrexate—bone cancer	0.0355	0.0544	CbGbCtD
Verapamil—ABCB11—Doxorubicin—bone cancer	0.0316	0.0486	CbGbCtD
Verapamil—ABCC2—Carboplatin—bone cancer	0.029	0.0446	CbGbCtD
Verapamil—ABCC4—Methotrexate—bone cancer	0.0271	0.0416	CbGbCtD
Verapamil—ABCG2—Carboplatin—bone cancer	0.0263	0.0403	CbGbCtD
Verapamil—ABCC2—Cisplatin—bone cancer	0.0248	0.0381	CbGbCtD
Verapamil—ABCC1—Doxorubicin—bone cancer	0.0225	0.0345	CbGbCtD
Verapamil—ABCG2—Cisplatin—bone cancer	0.0224	0.0345	CbGbCtD
Verapamil—ABCC1—Methotrexate—bone cancer	0.0218	0.0334	CbGbCtD
Verapamil—SLCO1A2—Methotrexate—bone cancer	0.0194	0.0298	CbGbCtD
Verapamil—SLCO1B1—Methotrexate—bone cancer	0.0183	0.0282	CbGbCtD
Verapamil—ABCC2—Doxorubicin—bone cancer	0.0166	0.0255	CbGbCtD
Verapamil—ABCC2—Methotrexate—bone cancer	0.0161	0.0247	CbGbCtD
Verapamil—CYP2B6—Cisplatin—bone cancer	0.0158	0.0242	CbGbCtD
Verapamil—ABCG2—Doxorubicin—bone cancer	0.015	0.0231	CbGbCtD
Verapamil—ABCG2—Methotrexate—bone cancer	0.0146	0.0224	CbGbCtD
Verapamil—CYP2B6—Doxorubicin—bone cancer	0.0106	0.0162	CbGbCtD
Verapamil—CYP2C9—Cisplatin—bone cancer	0.00834	0.0128	CbGbCtD
Verapamil—ABCB1—Cisplatin—bone cancer	0.00809	0.0124	CbGbCtD
Verapamil—ABCB1—Doxorubicin—bone cancer	0.00542	0.00833	CbGbCtD
Verapamil—ABCB1—Methotrexate—bone cancer	0.00525	0.00807	CbGbCtD
Verapamil—CYP2D6—Doxorubicin—bone cancer	0.00511	0.00785	CbGbCtD
Verapamil—CYP3A4—Doxorubicin—bone cancer	0.00325	0.00499	CbGbCtD
Verapamil—CACNA1S—pes—bone cancer	0.0019	0.435	CbGeAlD
Verapamil—Tofisopam—CYP3A4—bone cancer	0.00106	1	CrCbGaD
Verapamil—Cerebrovascular accident—Cisplatin—bone cancer	0.000393	0.0102	CcSEcCtD
Verapamil—Paralysis—Epirubicin—bone cancer	0.000393	0.0102	CcSEcCtD
Verapamil—Ileus—Epirubicin—bone cancer	0.000385	0.00998	CcSEcCtD
Verapamil—Nystagmus—Epirubicin—bone cancer	0.000382	0.00989	CcSEcCtD
Verapamil—Hepatotoxicity—Methotrexate—bone cancer	0.000377	0.00978	CcSEcCtD
Verapamil—Paralysis—Doxorubicin—bone cancer	0.000363	0.00941	CcSEcCtD
Verapamil—Ileus—Doxorubicin—bone cancer	0.000357	0.00924	CcSEcCtD
Verapamil—Petechiae—Methotrexate—bone cancer	0.000354	0.00918	CcSEcCtD
Verapamil—Nystagmus—Doxorubicin—bone cancer	0.000353	0.00915	CcSEcCtD
Verapamil—Orthostatic hypotension—Cisplatin—bone cancer	0.000352	0.00912	CcSEcCtD
Verapamil—Cramp muscle—Cisplatin—bone cancer	0.000347	0.00899	CcSEcCtD
Verapamil—Petechiae—Epirubicin—bone cancer	0.000331	0.00859	CcSEcCtD
Verapamil—Sweating increased—Cisplatin—bone cancer	0.000325	0.00841	CcSEcCtD
Verapamil—Abdominal discomfort—Cisplatin—bone cancer	0.000319	0.00827	CcSEcCtD
Verapamil—Hepatic enzyme increased—Methotrexate—bone cancer	0.000308	0.00798	CcSEcCtD
Verapamil—Petechiae—Doxorubicin—bone cancer	0.000307	0.00795	CcSEcCtD
Verapamil—Vasculitis—Methotrexate—bone cancer	0.000299	0.00774	CcSEcCtD
Verapamil—Respiratory failure—Methotrexate—bone cancer	0.000297	0.00769	CcSEcCtD
Verapamil—Acute coronary syndrome—Cisplatin—bone cancer	0.000293	0.00759	CcSEcCtD
Verapamil—Myocardial infarction—Cisplatin—bone cancer	0.000291	0.00754	CcSEcCtD
Verapamil—Atrioventricular block—Epirubicin—bone cancer	0.000281	0.00728	CcSEcCtD
Verapamil—Bradycardia—Cisplatin—bone cancer	0.000271	0.00703	CcSEcCtD
Verapamil—Ecchymosis—Methotrexate—bone cancer	0.000263	0.00683	CcSEcCtD
Verapamil—Gynaecomastia—Methotrexate—bone cancer	0.000261	0.00675	CcSEcCtD
Verapamil—Atrioventricular block—Doxorubicin—bone cancer	0.00026	0.00674	CcSEcCtD
Verapamil—Pulmonary oedema—Methotrexate—bone cancer	0.000259	0.00672	CcSEcCtD
Verapamil—Visual impairment—Cisplatin—bone cancer	0.000257	0.00666	CcSEcCtD
Verapamil—Tinnitus—Cisplatin—bone cancer	0.000249	0.00644	CcSEcCtD
Verapamil—Rash maculo-papular—Epirubicin—bone cancer	0.000248	0.00642	CcSEcCtD
Verapamil—Flushing—Cisplatin—bone cancer	0.000248	0.00641	CcSEcCtD
Verapamil—Ecchymosis—Epirubicin—bone cancer	0.000247	0.00639	CcSEcCtD
Verapamil—Pulmonary oedema—Epirubicin—bone cancer	0.000243	0.00629	CcSEcCtD
Verapamil—Alopecia—Cisplatin—bone cancer	0.000236	0.00611	CcSEcCtD
Verapamil—CACNA1B—connective tissue—bone cancer	0.00023	0.0527	CbGeAlD
Verapamil—Rash maculo-papular—Doxorubicin—bone cancer	0.000229	0.00594	CcSEcCtD
Verapamil—Ecchymosis—Doxorubicin—bone cancer	0.000228	0.00591	CcSEcCtD
Verapamil—Pulmonary oedema—Doxorubicin—bone cancer	0.000225	0.00582	CcSEcCtD
Verapamil—Muscle spasms—Cisplatin—bone cancer	0.000223	0.00578	CcSEcCtD
Verapamil—Vascular purpura—Epirubicin—bone cancer	0.000221	0.00573	CcSEcCtD
Verapamil—Vision blurred—Cisplatin—bone cancer	0.000219	0.00567	CcSEcCtD
Verapamil—Tremor—Cisplatin—bone cancer	0.000218	0.00563	CcSEcCtD
Verapamil—Cerebrovascular accident—Methotrexate—bone cancer	0.000216	0.00559	CcSEcCtD
Verapamil—Lethargy—Methotrexate—bone cancer	0.000216	0.00559	CcSEcCtD
Verapamil—Purpura—Epirubicin—bone cancer	0.000205	0.00532	CcSEcCtD
Verapamil—Vascular purpura—Doxorubicin—bone cancer	0.000205	0.0053	CcSEcCtD
Verapamil—Cardiac failure—Epirubicin—bone cancer	0.000203	0.00526	CcSEcCtD
Verapamil—Lethargy—Epirubicin—bone cancer	0.000202	0.00523	CcSEcCtD
Verapamil—Cerebrovascular accident—Epirubicin—bone cancer	0.000202	0.00523	CcSEcCtD
Verapamil—Convulsion—Cisplatin—bone cancer	0.000201	0.00521	CcSEcCtD
Verapamil—Diplopia—Epirubicin—bone cancer	0.000198	0.00513	CcSEcCtD
Verapamil—Myalgia—Cisplatin—bone cancer	0.000198	0.00512	CcSEcCtD
Verapamil—Discomfort—Cisplatin—bone cancer	0.000195	0.00506	CcSEcCtD
Verapamil—Purpura—Doxorubicin—bone cancer	0.00019	0.00492	CcSEcCtD
Verapamil—Oedema—Cisplatin—bone cancer	0.000189	0.00491	CcSEcCtD
Verapamil—Anaphylactic shock—Cisplatin—bone cancer	0.000189	0.00491	CcSEcCtD
Verapamil—Cardiac arrest—Epirubicin—bone cancer	0.000188	0.00488	CcSEcCtD
Verapamil—Infection—Cisplatin—bone cancer	0.000188	0.00488	CcSEcCtD
Verapamil—Cardiac failure—Doxorubicin—bone cancer	0.000188	0.00486	CcSEcCtD
Verapamil—Cerebrovascular accident—Doxorubicin—bone cancer	0.000187	0.00484	CcSEcCtD
Verapamil—Lethargy—Doxorubicin—bone cancer	0.000187	0.00484	CcSEcCtD
Verapamil—Tachycardia—Cisplatin—bone cancer	0.000185	0.00479	CcSEcCtD
Verapamil—Diplopia—Doxorubicin—bone cancer	0.000183	0.00475	CcSEcCtD
Verapamil—Hyperhidrosis—Cisplatin—bone cancer	0.000183	0.00475	CcSEcCtD
Verapamil—Orthostatic hypotension—Epirubicin—bone cancer	0.000181	0.00468	CcSEcCtD
Verapamil—Hypotension—Cisplatin—bone cancer	0.000177	0.00459	CcSEcCtD
Verapamil—Abdominal discomfort—Methotrexate—bone cancer	0.000175	0.00454	CcSEcCtD
Verapamil—Muscular weakness—Epirubicin—bone cancer	0.000175	0.00452	CcSEcCtD
Verapamil—Cardiac arrest—Doxorubicin—bone cancer	0.000174	0.00451	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000173	0.00447	CcSEcCtD
Verapamil—Influenza—Epirubicin—bone cancer	0.000171	0.00443	CcSEcCtD
Verapamil—Paraesthesia—Cisplatin—bone cancer	0.00017	0.00441	CcSEcCtD
Verapamil—Upper respiratory tract infection—Methotrexate—bone cancer	0.00017	0.0044	CcSEcCtD
Verapamil—CACNB4—tendon—bone cancer	0.00017	0.0389	CbGeAlD
Verapamil—Dyspnoea—Cisplatin—bone cancer	0.000169	0.00438	CcSEcCtD
Verapamil—Erectile dysfunction—Methotrexate—bone cancer	0.000168	0.00436	CcSEcCtD
Verapamil—Orthostatic hypotension—Doxorubicin—bone cancer	0.000167	0.00433	CcSEcCtD
Verapamil—Angina pectoris—Epirubicin—bone cancer	0.000167	0.00432	CcSEcCtD
Verapamil—CACNB4—spinal cord—bone cancer	0.000164	0.0375	CbGeAlD
Verapamil—Drowsiness—Methotrexate—bone cancer	0.000163	0.00422	CcSEcCtD
Verapamil—Pain—Cisplatin—bone cancer	0.000162	0.0042	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000162	0.00419	CcSEcCtD
Verapamil—Muscular weakness—Doxorubicin—bone cancer	0.000162	0.00419	CcSEcCtD
Verapamil—Upper respiratory tract infection—Epirubicin—bone cancer	0.000159	0.00412	CcSEcCtD
Verapamil—Influenza—Doxorubicin—bone cancer	0.000158	0.0041	CcSEcCtD
Verapamil—Pollakiuria—Epirubicin—bone cancer	0.000158	0.00409	CcSEcCtD
Verapamil—Sweating—Methotrexate—bone cancer	0.000156	0.00405	CcSEcCtD
Verapamil—Feeling abnormal—Cisplatin—bone cancer	0.000156	0.00404	CcSEcCtD
Verapamil—Angina pectoris—Doxorubicin—bone cancer	0.000154	0.004	CcSEcCtD
Verapamil—Drowsiness—Epirubicin—bone cancer	0.000153	0.00395	CcSEcCtD
Verapamil—CACNA1B—spinal cord—bone cancer	0.000152	0.035	CbGeAlD
Verapamil—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000151	0.00392	CcSEcCtD
Verapamil—Jaundice—Epirubicin—bone cancer	0.000149	0.00385	CcSEcCtD
Verapamil—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000147	0.00381	CcSEcCtD
Verapamil—Hepatitis—Methotrexate—bone cancer	0.000146	0.00379	CcSEcCtD
Verapamil—Sweating—Epirubicin—bone cancer	0.000146	0.00379	CcSEcCtD
Verapamil—Pollakiuria—Doxorubicin—bone cancer	0.000146	0.00379	CcSEcCtD
Verapamil—CACNA1S—tendon—bone cancer	0.000145	0.0333	CbGeAlD
Verapamil—Pharyngitis—Methotrexate—bone cancer	0.000145	0.00376	CcSEcCtD
Verapamil—Sinusitis—Epirubicin—bone cancer	0.000143	0.00371	CcSEcCtD
Verapamil—Drowsiness—Doxorubicin—bone cancer	0.000141	0.00366	CcSEcCtD
Verapamil—Visual impairment—Methotrexate—bone cancer	0.000141	0.00365	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00014	0.00363	CcSEcCtD
Verapamil—Hypersensitivity—Cisplatin—bone cancer	0.00014	0.00362	CcSEcCtD
Verapamil—Bradycardia—Epirubicin—bone cancer	0.000139	0.00361	CcSEcCtD
Verapamil—Erythema multiforme—Methotrexate—bone cancer	0.000138	0.00358	CcSEcCtD
Verapamil—Jaundice—Doxorubicin—bone cancer	0.000138	0.00356	CcSEcCtD
Verapamil—Rhinitis—Epirubicin—bone cancer	0.000137	0.00356	CcSEcCtD
Verapamil—Hepatitis—Epirubicin—bone cancer	0.000137	0.00355	CcSEcCtD
Verapamil—Tinnitus—Methotrexate—bone cancer	0.000136	0.00353	CcSEcCtD
Verapamil—Hypoaesthesia—Epirubicin—bone cancer	0.000136	0.00353	CcSEcCtD
Verapamil—Asthenia—Cisplatin—bone cancer	0.000136	0.00352	CcSEcCtD
Verapamil—Pharyngitis—Epirubicin—bone cancer	0.000136	0.00352	CcSEcCtD
Verapamil—CACNB1—tendon—bone cancer	0.000135	0.0311	CbGeAlD
Verapamil—Sweating—Doxorubicin—bone cancer	0.000135	0.00351	CcSEcCtD
Verapamil—Oedema peripheral—Epirubicin—bone cancer	0.000135	0.0035	CcSEcCtD
Verapamil—Sinusitis—Doxorubicin—bone cancer	0.000132	0.00343	CcSEcCtD
Verapamil—Visual impairment—Epirubicin—bone cancer	0.000132	0.00342	CcSEcCtD
Verapamil—CACNB1—spinal cord—bone cancer	0.000131	0.03	CbGeAlD
Verapamil—CACNB3—tendon—bone cancer	0.00013	0.0298	CbGeAlD
Verapamil—Diarrhoea—Cisplatin—bone cancer	0.00013	0.00336	CcSEcCtD
Verapamil—Erythema multiforme—Epirubicin—bone cancer	0.000129	0.00335	CcSEcCtD
Verapamil—Alopecia—Methotrexate—bone cancer	0.000129	0.00335	CcSEcCtD
Verapamil—Bradycardia—Doxorubicin—bone cancer	0.000129	0.00334	CcSEcCtD
Verapamil—Tinnitus—Epirubicin—bone cancer	0.000128	0.00331	CcSEcCtD
Verapamil—Flushing—Epirubicin—bone cancer	0.000127	0.00329	CcSEcCtD
Verapamil—Rhinitis—Doxorubicin—bone cancer	0.000127	0.00329	CcSEcCtD
Verapamil—Hepatitis—Doxorubicin—bone cancer	0.000127	0.00328	CcSEcCtD
Verapamil—Hypoaesthesia—Doxorubicin—bone cancer	0.000126	0.00327	CcSEcCtD
Verapamil—Pharyngitis—Doxorubicin—bone cancer	0.000126	0.00326	CcSEcCtD
Verapamil—Oedema peripheral—Doxorubicin—bone cancer	0.000125	0.00323	CcSEcCtD
Verapamil—Visual impairment—Doxorubicin—bone cancer	0.000122	0.00316	CcSEcCtD
Verapamil—Alopecia—Epirubicin—bone cancer	0.000121	0.00314	CcSEcCtD
Verapamil—Vomiting—Cisplatin—bone cancer	0.00012	0.00312	CcSEcCtD
Verapamil—Vision blurred—Methotrexate—bone cancer	0.00012	0.00311	CcSEcCtD
Verapamil—Erythema multiforme—Doxorubicin—bone cancer	0.00012	0.0031	CcSEcCtD
Verapamil—Rash—Cisplatin—bone cancer	0.000119	0.00309	CcSEcCtD
Verapamil—Dermatitis—Cisplatin—bone cancer	0.000119	0.00309	CcSEcCtD
Verapamil—Tinnitus—Doxorubicin—bone cancer	0.000118	0.00306	CcSEcCtD
Verapamil—Flushing—Doxorubicin—bone cancer	0.000118	0.00305	CcSEcCtD
Verapamil—Muscle spasms—Epirubicin—bone cancer	0.000115	0.00297	CcSEcCtD
Verapamil—Vertigo—Methotrexate—bone cancer	0.000114	0.00297	CcSEcCtD
Verapamil—Nausea—Cisplatin—bone cancer	0.000113	0.00292	CcSEcCtD
Verapamil—Vision blurred—Epirubicin—bone cancer	0.000112	0.00291	CcSEcCtD
Verapamil—Alopecia—Doxorubicin—bone cancer	0.000112	0.0029	CcSEcCtD
Verapamil—Convulsion—Methotrexate—bone cancer	0.00011	0.00286	CcSEcCtD
Verapamil—Agitation—Epirubicin—bone cancer	0.00011	0.00284	CcSEcCtD
Verapamil—Myalgia—Methotrexate—bone cancer	0.000108	0.00281	CcSEcCtD
Verapamil—Chest pain—Methotrexate—bone cancer	0.000108	0.00281	CcSEcCtD
Verapamil—Arthralgia—Methotrexate—bone cancer	0.000108	0.00281	CcSEcCtD
Verapamil—Discomfort—Methotrexate—bone cancer	0.000107	0.00278	CcSEcCtD
Verapamil—Vertigo—Epirubicin—bone cancer	0.000107	0.00277	CcSEcCtD
Verapamil—Syncope—Epirubicin—bone cancer	0.000107	0.00277	CcSEcCtD
Verapamil—Muscle spasms—Doxorubicin—bone cancer	0.000106	0.00275	CcSEcCtD
Verapamil—Palpitations—Epirubicin—bone cancer	0.000105	0.00273	CcSEcCtD
Verapamil—Confusional state—Methotrexate—bone cancer	0.000105	0.00272	CcSEcCtD
Verapamil—Loss of consciousness—Epirubicin—bone cancer	0.000105	0.00271	CcSEcCtD
Verapamil—Anaphylactic shock—Methotrexate—bone cancer	0.000104	0.00269	CcSEcCtD
Verapamil—Vision blurred—Doxorubicin—bone cancer	0.000104	0.00269	CcSEcCtD
Verapamil—Convulsion—Epirubicin—bone cancer	0.000103	0.00268	CcSEcCtD
Verapamil—Infection—Methotrexate—bone cancer	0.000103	0.00268	CcSEcCtD
Verapamil—Hypertension—Epirubicin—bone cancer	0.000103	0.00267	CcSEcCtD
Verapamil—CACNA1C—connective tissue—bone cancer	0.000102	0.0235	CbGeAlD
Verapamil—Myalgia—Epirubicin—bone cancer	0.000101	0.00263	CcSEcCtD
Verapamil—Chest pain—Epirubicin—bone cancer	0.000101	0.00263	CcSEcCtD
Verapamil—Arthralgia—Epirubicin—bone cancer	0.000101	0.00263	CcSEcCtD
Verapamil—Agitation—Doxorubicin—bone cancer	0.000101	0.00263	CcSEcCtD
Verapamil—Hyperhidrosis—Methotrexate—bone cancer	0.000101	0.0026	CcSEcCtD
Verapamil—Discomfort—Epirubicin—bone cancer	0.0001	0.0026	CcSEcCtD
Verapamil—Dry mouth—Epirubicin—bone cancer	9.93e-05	0.00257	CcSEcCtD
Verapamil—Vertigo—Doxorubicin—bone cancer	9.91e-05	0.00257	CcSEcCtD
Verapamil—Syncope—Doxorubicin—bone cancer	9.89e-05	0.00256	CcSEcCtD
Verapamil—Confusional state—Epirubicin—bone cancer	9.81e-05	0.00254	CcSEcCtD
Verapamil—Palpitations—Doxorubicin—bone cancer	9.75e-05	0.00253	CcSEcCtD
Verapamil—Oedema—Epirubicin—bone cancer	9.73e-05	0.00252	CcSEcCtD
Verapamil—Anaphylactic shock—Epirubicin—bone cancer	9.73e-05	0.00252	CcSEcCtD
Verapamil—Hypotension—Methotrexate—bone cancer	9.72e-05	0.00252	CcSEcCtD
Verapamil—Loss of consciousness—Doxorubicin—bone cancer	9.7e-05	0.00251	CcSEcCtD
Verapamil—Infection—Epirubicin—bone cancer	9.67e-05	0.0025	CcSEcCtD
Verapamil—Shock—Epirubicin—bone cancer	9.57e-05	0.00248	CcSEcCtD
Verapamil—Convulsion—Doxorubicin—bone cancer	9.56e-05	0.00248	CcSEcCtD
Verapamil—Hypertension—Doxorubicin—bone cancer	9.52e-05	0.00247	CcSEcCtD
Verapamil—Tachycardia—Epirubicin—bone cancer	9.5e-05	0.00246	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Methotrexate—bone cancer	9.47e-05	0.00245	CcSEcCtD
Verapamil—Hyperhidrosis—Epirubicin—bone cancer	9.41e-05	0.00244	CcSEcCtD
Verapamil—Insomnia—Methotrexate—bone cancer	9.4e-05	0.00244	CcSEcCtD
Verapamil—Chest pain—Doxorubicin—bone cancer	9.39e-05	0.00243	CcSEcCtD
Verapamil—Myalgia—Doxorubicin—bone cancer	9.39e-05	0.00243	CcSEcCtD
Verapamil—Arthralgia—Doxorubicin—bone cancer	9.39e-05	0.00243	CcSEcCtD
Verapamil—Paraesthesia—Methotrexate—bone cancer	9.34e-05	0.00242	CcSEcCtD
Verapamil—Discomfort—Doxorubicin—bone cancer	9.28e-05	0.0024	CcSEcCtD
Verapamil—Dyspnoea—Methotrexate—bone cancer	9.27e-05	0.0024	CcSEcCtD
Verapamil—Somnolence—Methotrexate—bone cancer	9.24e-05	0.00239	CcSEcCtD
Verapamil—Dry mouth—Doxorubicin—bone cancer	9.18e-05	0.00238	CcSEcCtD
Verapamil—Dyspepsia—Methotrexate—bone cancer	9.15e-05	0.00237	CcSEcCtD
Verapamil—Hypotension—Epirubicin—bone cancer	9.09e-05	0.00236	CcSEcCtD
Verapamil—Confusional state—Doxorubicin—bone cancer	9.08e-05	0.00235	CcSEcCtD
Verapamil—Anaphylactic shock—Doxorubicin—bone cancer	9e-05	0.00233	CcSEcCtD
Verapamil—Oedema—Doxorubicin—bone cancer	9e-05	0.00233	CcSEcCtD
Verapamil—Fatigue—Methotrexate—bone cancer	8.96e-05	0.00232	CcSEcCtD
Verapamil—Infection—Doxorubicin—bone cancer	8.94e-05	0.00232	CcSEcCtD
Verapamil—Pain—Methotrexate—bone cancer	8.89e-05	0.0023	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Epirubicin—bone cancer	8.86e-05	0.0023	CcSEcCtD
Verapamil—Shock—Doxorubicin—bone cancer	8.86e-05	0.00229	CcSEcCtD
Verapamil—Insomnia—Epirubicin—bone cancer	8.8e-05	0.00228	CcSEcCtD
Verapamil—Tachycardia—Doxorubicin—bone cancer	8.79e-05	0.00228	CcSEcCtD
Verapamil—Paraesthesia—Epirubicin—bone cancer	8.74e-05	0.00226	CcSEcCtD
Verapamil—CACNB2—tendon—bone cancer	8.73e-05	0.02	CbGeAlD
Verapamil—Hyperhidrosis—Doxorubicin—bone cancer	8.7e-05	0.00225	CcSEcCtD
Verapamil—Dyspnoea—Epirubicin—bone cancer	8.67e-05	0.00225	CcSEcCtD
Verapamil—Somnolence—Epirubicin—bone cancer	8.65e-05	0.00224	CcSEcCtD
Verapamil—Feeling abnormal—Methotrexate—bone cancer	8.57e-05	0.00222	CcSEcCtD
Verapamil—Dyspepsia—Epirubicin—bone cancer	8.56e-05	0.00222	CcSEcCtD
Verapamil—Hypotension—Doxorubicin—bone cancer	8.41e-05	0.00218	CcSEcCtD
Verapamil—Fatigue—Epirubicin—bone cancer	8.39e-05	0.00217	CcSEcCtD
Verapamil—Pain—Epirubicin—bone cancer	8.32e-05	0.00216	CcSEcCtD
Verapamil—Constipation—Epirubicin—bone cancer	8.32e-05	0.00216	CcSEcCtD
Verapamil—KCNJ11—tendon—bone cancer	8.28e-05	0.019	CbGeAlD
Verapamil—Urticaria—Methotrexate—bone cancer	8.26e-05	0.00214	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Doxorubicin—bone cancer	8.2e-05	0.00212	CcSEcCtD
Verapamil—Insomnia—Doxorubicin—bone cancer	8.14e-05	0.00211	CcSEcCtD
Verapamil—Paraesthesia—Doxorubicin—bone cancer	8.08e-05	0.00209	CcSEcCtD
Verapamil—Dyspnoea—Doxorubicin—bone cancer	8.03e-05	0.00208	CcSEcCtD
Verapamil—Feeling abnormal—Epirubicin—bone cancer	8.02e-05	0.00208	CcSEcCtD
Verapamil—Somnolence—Doxorubicin—bone cancer	8e-05	0.00207	CcSEcCtD
Verapamil—Dyspepsia—Doxorubicin—bone cancer	7.92e-05	0.00205	CcSEcCtD
Verapamil—Fatigue—Doxorubicin—bone cancer	7.76e-05	0.00201	CcSEcCtD
Verapamil—Urticaria—Epirubicin—bone cancer	7.73e-05	0.002	CcSEcCtD
Verapamil—Constipation—Doxorubicin—bone cancer	7.7e-05	0.00199	CcSEcCtD
Verapamil—Pain—Doxorubicin—bone cancer	7.7e-05	0.00199	CcSEcCtD
Verapamil—Hypersensitivity—Methotrexate—bone cancer	7.66e-05	0.00198	CcSEcCtD
Verapamil—Asthenia—Methotrexate—bone cancer	7.46e-05	0.00193	CcSEcCtD
Verapamil—Feeling abnormal—Doxorubicin—bone cancer	7.42e-05	0.00192	CcSEcCtD
Verapamil—Pruritus—Methotrexate—bone cancer	7.36e-05	0.00191	CcSEcCtD
Verapamil—Hypersensitivity—Epirubicin—bone cancer	7.17e-05	0.00186	CcSEcCtD
Verapamil—Urticaria—Doxorubicin—bone cancer	7.15e-05	0.00185	CcSEcCtD
Verapamil—Diarrhoea—Methotrexate—bone cancer	7.11e-05	0.00184	CcSEcCtD
Verapamil—Asthenia—Epirubicin—bone cancer	6.98e-05	0.00181	CcSEcCtD
Verapamil—Pruritus—Epirubicin—bone cancer	6.88e-05	0.00178	CcSEcCtD
Verapamil—Dizziness—Methotrexate—bone cancer	6.88e-05	0.00178	CcSEcCtD
Verapamil—Diarrhoea—Epirubicin—bone cancer	6.66e-05	0.00172	CcSEcCtD
Verapamil—Hypersensitivity—Doxorubicin—bone cancer	6.63e-05	0.00172	CcSEcCtD
Verapamil—Vomiting—Methotrexate—bone cancer	6.61e-05	0.00171	CcSEcCtD
Verapamil—Rash—Methotrexate—bone cancer	6.56e-05	0.0017	CcSEcCtD
Verapamil—Dermatitis—Methotrexate—bone cancer	6.55e-05	0.0017	CcSEcCtD
Verapamil—Headache—Methotrexate—bone cancer	6.51e-05	0.00169	CcSEcCtD
Verapamil—Asthenia—Doxorubicin—bone cancer	6.46e-05	0.00167	CcSEcCtD
Verapamil—Dizziness—Epirubicin—bone cancer	6.43e-05	0.00167	CcSEcCtD
Verapamil—ABCC10—tendon—bone cancer	6.38e-05	0.0146	CbGeAlD
Verapamil—Pruritus—Doxorubicin—bone cancer	6.37e-05	0.00165	CcSEcCtD
Verapamil—Vomiting—Epirubicin—bone cancer	6.19e-05	0.0016	CcSEcCtD
Verapamil—ABCC10—bone marrow—bone cancer	6.18e-05	0.0142	CbGeAlD
Verapamil—Nausea—Methotrexate—bone cancer	6.18e-05	0.0016	CcSEcCtD
Verapamil—Diarrhoea—Doxorubicin—bone cancer	6.16e-05	0.0016	CcSEcCtD
Verapamil—ABCC10—spinal cord—bone cancer	6.15e-05	0.0141	CbGeAlD
Verapamil—Rash—Epirubicin—bone cancer	6.13e-05	0.00159	CcSEcCtD
Verapamil—Dermatitis—Epirubicin—bone cancer	6.13e-05	0.00159	CcSEcCtD
Verapamil—Headache—Epirubicin—bone cancer	6.1e-05	0.00158	CcSEcCtD
Verapamil—SLC22A4—tendon—bone cancer	5.99e-05	0.0137	CbGeAlD
Verapamil—Dizziness—Doxorubicin—bone cancer	5.95e-05	0.00154	CcSEcCtD
Verapamil—SLC22A4—bone marrow—bone cancer	5.81e-05	0.0133	CbGeAlD
Verapamil—SLC22A4—spinal cord—bone cancer	5.78e-05	0.0133	CbGeAlD
Verapamil—Nausea—Epirubicin—bone cancer	5.78e-05	0.0015	CcSEcCtD
Verapamil—Vomiting—Doxorubicin—bone cancer	5.72e-05	0.00148	CcSEcCtD
Verapamil—Rash—Doxorubicin—bone cancer	5.68e-05	0.00147	CcSEcCtD
Verapamil—Dermatitis—Doxorubicin—bone cancer	5.67e-05	0.00147	CcSEcCtD
Verapamil—Headache—Doxorubicin—bone cancer	5.64e-05	0.00146	CcSEcCtD
Verapamil—Nausea—Doxorubicin—bone cancer	5.35e-05	0.00139	CcSEcCtD
Verapamil—SLCO1A2—spinal cord—bone cancer	5.3e-05	0.0122	CbGeAlD
Verapamil—ABCC4—tendon—bone cancer	5.29e-05	0.0121	CbGeAlD
Verapamil—ABCC4—bone marrow—bone cancer	5.12e-05	0.0117	CbGeAlD
Verapamil—SLC6A4—spinal cord—bone cancer	5.12e-05	0.0117	CbGeAlD
Verapamil—ABCC2—tendon—bone cancer	5.12e-05	0.0117	CbGeAlD
Verapamil—ABCC1—tendon—bone cancer	4.51e-05	0.0103	CbGeAlD
Verapamil—KCNH2—bone marrow—bone cancer	4.07e-05	0.00932	CbGeAlD
Verapamil—CYP2C9—Biological oxidations—CYP3A4—bone cancer	4.06e-05	0.000431	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—MMP2—bone cancer	4.06e-05	0.00043	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—MMP2—bone cancer	4.06e-05	0.00043	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—JUN—bone cancer	4.05e-05	0.000429	CbGpPWpGaD
Verapamil—KCNH2—spinal cord—bone cancer	4.05e-05	0.00928	CbGeAlD
Verapamil—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	4.04e-05	0.000428	CbGpPWpGaD
Verapamil—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	4.01e-05	0.000425	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	4e-05	0.000424	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—NT5C3A—bone cancer	3.99e-05	0.000424	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—GSTP1—bone cancer	3.98e-05	0.000422	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	3.98e-05	0.000422	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—MDM2—bone cancer	3.98e-05	0.000422	CbGpPWpGaD
Verapamil—SLC22A5—tendon—bone cancer	3.97e-05	0.0091	CbGeAlD
Verapamil—CYP3A7—Metabolism—NT5C3A—bone cancer	3.96e-05	0.00042	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—MET—bone cancer	3.95e-05	0.000419	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—CDK4—bone cancer	3.95e-05	0.000419	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	3.94e-05	0.000418	CbGpPWpGaD
Verapamil—SLC22A5—spinal cord—bone cancer	3.83e-05	0.00877	CbGeAlD
Verapamil—CYP2C19—Biological oxidations—GSTP1—bone cancer	3.81e-05	0.000404	CbGpPWpGaD
Verapamil—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	3.76e-05	0.000398	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—GSTP1—bone cancer	3.75e-05	0.000397	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	3.74e-05	0.000396	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—MMP9—bone cancer	3.71e-05	0.000393	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—NT5C3A—bone cancer	3.68e-05	0.000391	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—MMP9—bone cancer	3.66e-05	0.000388	CbGpPWpGaD
Verapamil—ABCG2—bone marrow—bone cancer	3.62e-05	0.00829	CbGeAlD
Verapamil—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	3.61e-05	0.000382	CbGpPWpGaD
Verapamil—ABCG2—spinal cord—bone cancer	3.6e-05	0.00826	CbGeAlD
Verapamil—CACNA1H—Developmental Biology—MMP9—bone cancer	3.59e-05	0.000381	CbGpPWpGaD
Verapamil—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	3.54e-05	0.000375	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—NDUFA12—bone cancer	3.53e-05	0.000375	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—MET—bone cancer	3.51e-05	0.000372	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—CDK4—bone cancer	3.51e-05	0.000372	CbGpPWpGaD
Verapamil—CYP2D6—Biological oxidations—GSTP1—bone cancer	3.5e-05	0.000372	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—MMP2—bone cancer	3.48e-05	0.000369	CbGpPWpGaD
Verapamil—CYP2C9—Biological oxidations—GSTP1—bone cancer	3.47e-05	0.000368	CbGpPWpGaD
Verapamil—CYP1A2—Biological oxidations—CYP3A4—bone cancer	3.47e-05	0.000368	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—MET—bone cancer	3.47e-05	0.000368	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—CDK4—bone cancer	3.47e-05	0.000368	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—MMP9—bone cancer	3.47e-05	0.000368	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—EGFR—bone cancer	3.46e-05	0.000367	CbGpPWpGaD
Verapamil—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	3.46e-05	0.000366	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NDUFA12—bone cancer	3.45e-05	0.000366	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—EGFR—bone cancer	3.45e-05	0.000366	CbGpPWpGaD
Verapamil—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	3.43e-05	0.000363	CbGpPWpGaD
Verapamil—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	3.42e-05	0.000363	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—ENO2—bone cancer	3.4e-05	0.000361	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—EGFR—bone cancer	3.36e-05	0.000357	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	3.34e-05	0.000354	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.33e-05	0.000353	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—MMP2—bone cancer	3.29e-05	0.000349	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—ENO2—bone cancer	3.25e-05	0.000344	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—ENO2—bone cancer	3.22e-05	0.000342	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—DHFR—bone cancer	3.16e-05	0.000335	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	3.13e-05	0.000332	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	3.13e-05	0.000332	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—MMP9—bone cancer	3.08e-05	0.000327	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—MMP9—bone cancer	3.05e-05	0.000323	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—MMP9—bone cancer	3.05e-05	0.000323	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—PLAU—bone cancer	3.03e-05	0.000322	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	3.02e-05	0.00032	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—DHFR—bone cancer	3.01e-05	0.000319	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—EGFR—bone cancer	3e-05	0.000318	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NDUFA12—bone cancer	2.99e-05	0.000317	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—DHFR—bone cancer	2.99e-05	0.000317	CbGpPWpGaD
Verapamil—CYP1A2—Biological oxidations—GSTP1—bone cancer	2.97e-05	0.000315	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—EGFR—bone cancer	2.96e-05	0.000314	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—GNA11—bone cancer	2.95e-05	0.000313	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—NT5C3A—bone cancer	2.93e-05	0.00031	CbGpPWpGaD
Verapamil—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	2.93e-05	0.00031	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—MMP2—bone cancer	2.93e-05	0.00031	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—EGFR—bone cancer	2.9e-05	0.000308	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—MMP2—bone cancer	2.89e-05	0.000307	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.88e-05	0.000305	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NT5C3A—bone cancer	2.86e-05	0.000303	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ENO2—bone cancer	2.83e-05	0.0003	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—GNA11—bone cancer	2.81e-05	0.000298	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—EGFR—bone cancer	2.8e-05	0.000297	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—GNA11—bone cancer	2.79e-05	0.000296	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—BRAF—bone cancer	2.76e-05	0.000293	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—CYP3A4—bone cancer	2.68e-05	0.000284	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—TP53—bone cancer	2.67e-05	0.000283	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NDUFA12—bone cancer	2.67e-05	0.000283	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ENO2—bone cancer	2.65e-05	0.000281	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—DHFR—bone cancer	2.63e-05	0.000279	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—MMP9—bone cancer	2.61e-05	0.000277	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ENO2—bone cancer	2.61e-05	0.000277	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NDUFA12—bone cancer	2.61e-05	0.000276	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—CYP3A4—bone cancer	2.55e-05	0.000271	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ENO2—bone cancer	2.54e-05	0.000269	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—CYP3A4—bone cancer	2.53e-05	0.000269	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—EGFR—bone cancer	2.49e-05	0.000264	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.48e-05	0.000263	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NT5C3A—bone cancer	2.48e-05	0.000263	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—MMP9—bone cancer	2.48e-05	0.000263	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—EGFR—bone cancer	2.46e-05	0.000261	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—EGFR—bone cancer	2.46e-05	0.000261	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NDUFA12—bone cancer	2.46e-05	0.00026	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—DHFR—bone cancer	2.46e-05	0.00026	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—GNA11—bone cancer	2.46e-05	0.00026	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NDUFA12—bone cancer	2.43e-05	0.000258	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—DHFR—bone cancer	2.42e-05	0.000257	CbGpPWpGaD
Verapamil—ABCC1—Disease—ENO2—bone cancer	2.37e-05	0.000252	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—DHFR—bone cancer	2.35e-05	0.00025	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—MDM2—bone cancer	2.32e-05	0.000246	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—GNA11—bone cancer	2.29e-05	0.000243	CbGpPWpGaD
Verapamil—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.29e-05	0.000243	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—GSTP1—bone cancer	2.29e-05	0.000243	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—GNA11—bone cancer	2.26e-05	0.00024	CbGpPWpGaD
Verapamil—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.26e-05	0.00024	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—CYP3A4—bone cancer	2.23e-05	0.000236	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NT5C3A—bone cancer	2.21e-05	0.000235	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ENO2—bone cancer	2.21e-05	0.000234	CbGpPWpGaD
Verapamil—ABCC1—Disease—DHFR—bone cancer	2.2e-05	0.000234	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—GNA11—bone cancer	2.2e-05	0.000233	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—MMP9—bone cancer	2.2e-05	0.000233	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—GSTP1—bone cancer	2.18e-05	0.000231	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—MMP9—bone cancer	2.18e-05	0.000231	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—GSTP1—bone cancer	2.17e-05	0.00023	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NT5C3A—bone cancer	2.16e-05	0.000229	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—EGFR—bone cancer	2.11e-05	0.000224	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NDUFA12—bone cancer	2.08e-05	0.000221	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—CYP3A4—bone cancer	2.08e-05	0.000221	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.07e-05	0.000219	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—PTGS2—bone cancer	2.06e-05	0.000219	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—CYP3A4—bone cancer	2.05e-05	0.000217	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—DHFR—bone cancer	2.05e-05	0.000217	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NT5C3A—bone cancer	2.03e-05	0.000216	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NT5C3A—bone cancer	2.02e-05	0.000214	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—EGFR—bone cancer	2e-05	0.000212	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CYP3A4—bone cancer	1.99e-05	0.000211	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ENO2—bone cancer	1.99e-05	0.000211	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.98e-05	0.00021	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PTGS2—bone cancer	1.94e-05	0.000206	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—GNA11—bone cancer	1.92e-05	0.000203	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—GSTP1—bone cancer	1.9e-05	0.000202	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ENO2—bone cancer	1.89e-05	0.0002	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—DHFR—bone cancer	1.84e-05	0.000196	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.84e-05	0.000195	CbGpPWpGaD
Verapamil—ABCB1—bone marrow—bone cancer	1.78e-05	0.00409	CbGeAlD
Verapamil—ABCB11—Metabolism—GSTP1—bone cancer	1.78e-05	0.000189	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—EGFR—bone cancer	1.78e-05	0.000188	CbGpPWpGaD
Verapamil—ABCB1—spinal cord—bone cancer	1.78e-05	0.00407	CbGeAlD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.77e-05	0.000188	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—EGFR—bone cancer	1.76e-05	0.000186	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—GSTP1—bone cancer	1.75e-05	0.000186	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—DHFR—bone cancer	1.75e-05	0.000186	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ENO2—bone cancer	1.75e-05	0.000186	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CYP3A4—bone cancer	1.74e-05	0.000184	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ENO2—bone cancer	1.73e-05	0.000184	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.73e-05	0.000183	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—GNA11—bone cancer	1.72e-05	0.000183	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NT5C3A—bone cancer	1.72e-05	0.000183	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—GSTP1—bone cancer	1.71e-05	0.000181	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GNA11—bone cancer	1.64e-05	0.000174	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—DHFR—bone cancer	1.62e-05	0.000172	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ENO2—bone cancer	1.61e-05	0.000171	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—DHFR—bone cancer	1.61e-05	0.000171	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NDUFA12—bone cancer	1.61e-05	0.00017	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.6e-05	0.000169	CbGpPWpGaD
Verapamil—ABCC1—Disease—TGFBR2—bone cancer	1.6e-05	0.000169	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CYP3A4—bone cancer	1.56e-05	0.000166	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.55e-05	0.000165	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GNA11—bone cancer	1.52e-05	0.000161	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GNA11—bone cancer	1.5e-05	0.000159	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—DHFR—bone cancer	1.5e-05	0.000159	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—GSTP1—bone cancer	1.49e-05	0.000158	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CYP3A4—bone cancer	1.49e-05	0.000157	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.48e-05	0.000157	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GNA11—bone cancer	1.4e-05	0.000148	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CYP3A4—bone cancer	1.38e-05	0.000146	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CYP3A4—bone cancer	1.36e-05	0.000145	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—GSTP1—bone cancer	1.34e-05	0.000142	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NT5C3A—bone cancer	1.33e-05	0.000141	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ENO2—bone cancer	1.28e-05	0.000136	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GSTP1—bone cancer	1.27e-05	0.000135	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CYP3A4—bone cancer	1.27e-05	0.000135	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.26e-05	0.000133	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ENO2—bone cancer	1.25e-05	0.000133	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—bone cancer	1.22e-05	0.000129	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—DHFR—bone cancer	1.19e-05	0.000126	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PTGS2—bone cancer	1.19e-05	0.000126	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GSTP1—bone cancer	1.18e-05	0.000125	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GSTP1—bone cancer	1.17e-05	0.000124	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—DHFR—bone cancer	1.16e-05	0.000123	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PTGS2—bone cancer	1.13e-05	0.00012	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PTGS2—bone cancer	1.12e-05	0.000119	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GNA11—bone cancer	1.11e-05	0.000118	CbGpPWpGaD
Verapamil—ABCC1—Disease—KIT—bone cancer	1.09e-05	0.000115	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GNA11—bone cancer	1.09e-05	0.000115	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ENO2—bone cancer	1.09e-05	0.000115	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GSTP1—bone cancer	1.08e-05	0.000115	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.05e-05	0.000112	CbGpPWpGaD
Verapamil—ABCC1—Disease—BRAF—bone cancer	1.02e-05	0.000109	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP3A4—bone cancer	1.01e-05	0.000107	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—DHFR—bone cancer	1.01e-05	0.000107	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTGS2—bone cancer	9.86e-06	0.000105	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP3A4—bone cancer	9.85e-06	0.000104	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ENO2—bone cancer	9.69e-06	0.000103	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ENO2—bone cancer	9.46e-06	0.0001	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GNA11—bone cancer	9.41e-06	9.98e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTGS2—bone cancer	9.22e-06	9.77e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTGS2—bone cancer	9.08e-06	9.63e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—DHFR—bone cancer	8.99e-06	9.53e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ENO2—bone cancer	8.91e-06	9.45e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTGS2—bone cancer	8.84e-06	9.37e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ENO2—bone cancer	8.84e-06	9.37e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—DHFR—bone cancer	8.77e-06	9.3e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GSTP1—bone cancer	8.62e-06	9.14e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MDM2—bone cancer	8.58e-06	9.09e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP3A4—bone cancer	8.53e-06	9.05e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.49e-06	9e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GSTP1—bone cancer	8.43e-06	8.94e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GNA11—bone cancer	8.4e-06	8.91e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—DHFR—bone cancer	8.27e-06	8.77e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTGS2—bone cancer	8.27e-06	8.77e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GNA11—bone cancer	8.2e-06	8.7e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—DHFR—bone cancer	8.2e-06	8.69e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GNA11—bone cancer	7.73e-06	8.19e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTGS2—bone cancer	7.7e-06	8.16e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GNA11—bone cancer	7.66e-06	8.12e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP3A4—bone cancer	7.62e-06	8.08e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.58e-06	8.04e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ENO2—bone cancer	7.55e-06	8.01e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP3A4—bone cancer	7.43e-06	7.88e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSTP1—bone cancer	7.3e-06	7.74e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP3A4—bone cancer	7.01e-06	7.43e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—DHFR—bone cancer	7e-06	7.43e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP3A4—bone cancer	6.95e-06	7.37e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTGS2—bone cancer	6.92e-06	7.34e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.91e-06	7.33e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTGS2—bone cancer	6.58e-06	6.98e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GNA11—bone cancer	6.55e-06	6.94e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTP1—bone cancer	6.51e-06	6.91e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTP1—bone cancer	6.36e-06	6.74e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—bone cancer	6.09e-06	6.46e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—bone cancer	6.04e-06	6.4e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTP1—bone cancer	5.99e-06	6.35e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTP1—bone cancer	5.94e-06	6.3e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP3A4—bone cancer	5.94e-06	6.29e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.91e-06	6.26e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—bone cancer	5.86e-06	6.22e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ENO2—bone cancer	5.83e-06	6.18e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—bone cancer	5.62e-06	5.96e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—DHFR—bone cancer	5.41e-06	5.73e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTP1—bone cancer	5.08e-06	5.38e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GNA11—bone cancer	5.05e-06	5.36e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—bone cancer	4.47e-06	4.74e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—bone cancer	4.37e-06	4.63e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTP1—bone cancer	3.92e-06	4.15e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—bone cancer	3.78e-06	4.01e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—bone cancer	3.38e-06	3.58e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—bone cancer	3.29e-06	3.49e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—bone cancer	3.1e-06	3.29e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—bone cancer	3.08e-06	3.26e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—bone cancer	2.63e-06	2.79e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—bone cancer	2.03e-06	2.15e-05	CbGpPWpGaD
